PIK3CA mutations were detected twice as frequently as predicted in cervical cancer (N = 23 predicted and N = 51 detected) and in endometrial cancer (N = 32 predicted and N = 71 detected). This evidence concerns the gene PIK3CA and endometrial cancer.